RUNX1 and leukemia: KAT6B has been shown to be transcriptional coregulator that physically and functionally interacts with the Runt-related transcription factor 1 (RUNX1), a recurrent leukemia-associated target, and the nuclear receptor peroxisome proliferator-activated receptor-α (PPARα) to exert its role [47, 48].